For the quarter ending 2026-03-31, PTHS has $145,378,000 in assets. $110,276,000 in debts. $31,976,000 in cash and cash equivalents.
| Balance Sheets | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Prepaid expenses and other current assets | - | - | 3,424,000 | 12,341 |
| Deferred offering costs | - | - | - | 710,937 |
| Due from chromocell corporation | - | - | - | 40,400 |
| Cash and cash equivalents | 31,976,000 | 17,973,000 | 14,203,000 | 59,172 |
| Restricted cash, current | 250,000 | 50,000 | 50,000 | - |
| Accounts receivable, net | 11,700,000 | 8,858,000 | 7,988,000 | - |
| Inventory, net | 23,418,000 | 23,574,000 | 24,096,000 | - |
| Prepaid expenses and other current assets | 2,457,000 | 2,955,000 | - | - |
| Total current assets | 69,801,000 | 53,410,000 | 49,761,000 | 822,850 |
| Property and equipment, net | 9,310,000 | 9,586,000 | 10,174,000 | - |
| Operating lease right-of-use assets, net | 3,146,000 | 3,250,000 | 3,352,000 | - |
| 2026 (april 1 - december 31) | 3,143,000 | - | - | - |
| 2027 | 4,175,000 | 4,174,000 | - | - |
| 2028 | 3,975,000 | 4,174,000 | - | - |
| 2029 | 3,830,000 | 3,965,000 | - | - |
| 2030 | 3,822,000 | 3,830,000 | - | - |
| 2030 | - | 3,822,000 | - | - |
| 2031 and thereafter | 19,495,000 | 19,505,000 | - | - |
| Intangible assets, net | 38,440,000 | 39,470,000 | 32,521,000 | - |
| Goodwill | 24,681,000 | 24,681,000 | 30,625,000 | - |
| Total assets | 145,378,000 | 130,397,000 | 126,433,000 | 822,850 |
| Accounts payable | 6,147,000 | 2,986,000 | 5,666,000 | - |
| Loan payable, net of debt discount | - | - | - | 2,172,819 |
| Loan payable - related party, net of debt discount | - | - | - | 131,868 |
| Accrued expenses | 12,835,000 | 15,364,000 | 11,890,000 | 23,636 |
| Contingent consideration | 1,000,000 | 2,200,000 | - | - |
| Operating lease liabilities, current portion | 640,000 | 635,000 | 631,000 | - |
| Deferred revenue, current portion | 978,000 | 966,000 | - | - |
| Loan payable, net of debt discount-Nonrelated Party | - | 0 | - | - |
| Loan payable, net of debt discount-Related Party | - | 0 | - | - |
| Deferred revenue, current portion | - | - | 1,019,000 | - |
| Accounts payable and accrued expenses | - | - | - | 4,988,822 |
| Other liabilities | 3,403,000 | 3,842,000 | 5,562,000 | - |
| Total current liabilities | 25,003,000 | 25,993,000 | 24,768,000 | 7,317,145 |
| Operating lease liabilities, net of current portion | 2,652,000 | 2,752,000 | - | - |
| Deferred revenue, net of current portion | 1,027,000 | 1,280,000 | - | - |
| Convertible debt | 23,283,000 | 31,441,000 | - | - |
| Venture loan and security agreement, net | 26,356,000 | - | - | - |
| Operating lease liabilities, net of current portion | - | - | 2,849,000 | - |
| Deferred revenue, net of current portion | - | - | 1,522,000 | - |
| Deferred income tax liability | - | - | 12,866,000 | - |
| Other long-term liabilities | 31,955,000 | 30,050,000 | 26,175,000 | - |
| Total liabilities | 110,276,000 | 91,516,000 | 68,180,000 | 7,317,145 |
| Preferred stock, value-Series APreferred Stock | 0 | 0 | - | 0 |
| Preferred stock, value-Series CPreferred Stock | 0 | 0 | - | 0 |
| Common stock, value | 0 | 0 | - | 67 |
| Additional paid in capital | 106,945,000 | 103,675,000 | 101,383,000 | 20,397,175 |
| Accumulated other comprehensive income | 3,189,000 | - | - | - |
| Accumulated deficit | -75,032,000 | -64,794,000 | -43,130,000 | -26,891,537 |
| Total stockholders' equity | 35,102,000 | 38,881,000 | 58,253,000 | -6,494,295 |
| Total liabilities and stockholders' equity | 145,378,000 | 130,397,000 | 126,433,000 | 822,850 |
Pelthos Therapeutics Inc. (PTHS)
Pelthos Therapeutics Inc. (PTHS)